Thyroid Cancer Transgenic Mouse Models

Solutions

Online Inquiry

Name *

Email *

Phone *

Services Interested *

Project Description

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Alfa Cytology excels in developing advanced transgenic mouse models specifically designed for thyroid cancer research. Our commitment focuses on delivering high-quality, reliable transgenic models that empower researchers worldwide to enhance and expedite the drug discovery process for thyroid cancer therapies.

Introduction to Transgenic Mouse Models

Transgenic mouse models are developed by incorporating specific genetic modifications that mimic the characteristics of human thyroid cancer. Models such as those featuring BRAF^V600E mutations or RET alterations create a biological environment that closely resembles the tumor dynamics observed in patients. This allows researchers to thoroughly investigate key aspects such as tumor initiation, growth patterns, metastasis, and responses to various drug treatments. Furthermore, these models serve as valuable platforms for assessing the effectiveness of novel therapeutic approaches, fostering advancements in the development of targeted therapies for thyroid cancer.

Characteristics of Thyroid Cancer Transgenic Mouse Models

Genetic Modifications: Common alterations include BRAF, RAS mutations, and RET/PTC rearrangements. Inducible systems (e.g., Cre-lox) allow controlled gene expression.
Promoter Specificity: Thyroid-specific promoters ensure targeted transgene expression in thyroid cells.
Tumor Subtypes: Models represent various subtypes, such as papillary, follicular, anaplastic, and medullary.
Pathological Features: Tumor onset varies, histopathology mirrors human features, and some models exhibit metastasis.

Our Services

Gene Editing and Model Construction

Targeted Gene Design: Introduce oncogenes like BRAF^V600E and RET/PTC to model various thyroid cancer subtypes.
Conditional Knockout/Knockin: Use Cre-loxP or Tet-On/Off systems for targeted gene regulation in thyroid cells.
Promoter Selection: Employ thyroid-specific promoters for precise expression.

Model Validation and Phenotypic Analysis

Molecular Validation: Confirm transgene expression via qPCR and Western blot; validate mutations using whole-exome sequencing.
Pathological Analysis: Assess histological features through H&E staining and IHC for key markers.
Functional Monitoring: Track tumor progression with imaging and evaluate thyroid function through serum tests.

Support for Disease Progression Research

Drug Testing: Evaluate targeted therapies and immunotherapies for efficacy and resistance mechanisms.
Metastatic Model Development: Create models to study metastasis mechanisms.

Alfa Cytology is your premier partner for developing thyroid cancer transgenic mouse models, supported by our extensive expertise in oncology research. We provide ready-to-use models, customizable options, and collaborative R&D services designed to meet your specific requirements. From comprehensive solutions to detailed reports, we offer full support. Contact us for inquiries or to discuss custom model development.

For research use only.